BRCA1 MUTATIONS IN PRIMARY BREAST AND OVARIAN CARCINOMAS

被引:1096
|
作者
FUTREAL, PA
LIU, QY
SHATTUCKEIDENS, D
COCHRAN, C
HARSHMAN, K
TAVTIGIAN, S
BENNETT, LM
HAUGENSTRANO, A
SWENSEN, J
MIKI, Y
EDDINGTON, K
MCCLURE, M
FRYE, C
WEAVERFELDHAUS, J
DING, W
GHOLAMI, Z
SODERKVIST, P
TERRY, L
JHANWAR, S
BERCHUCK, A
IGLEHART, JD
MARKS, J
BALLINGER, DG
BARRETT, JC
SKOLNICK, MH
KAMB, A
WISEMAN, R
机构
[1] MYRIAD GENET,SALT LAKE CITY,UT 84108
[2] UNIV UTAH,MED CTR,DEPT MED INFORMAT,SALT LAKE CITY,UT 84123
[3] FAC HLTH SCI LINKOPING,DEPT OCCUPAT MED,S-58185 LINKOPING,SWEDEN
[4] MEM SLOAN KETTERING CANC CTR,DEPT HUMAN GENET,NEW YORK,NY 10021
[5] DUKE UNIV,MED CTR,DEPT GYNECOL ONCOL,DURHAM,NC 27710
[6] DUKE UNIV,MED CTR,DEPT SURG,DURHAM,NC 27710
关键词
D O I
10.1126/science.7939630
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Loss of heterozygosity data from familial tumors suggest that BRCA1, a gene that confers susceptibility to ovarian and early-onset breast cancer, encodes a tumor suppressor. The BRCA1 region is also subject to allelic loss in sporadic breast and ovarian cancers, an indication that BRCA1 mutations may occur somatically in these tumors. The BRCA1 coding region was examined for mutations in primary breast and ovarian tumors that show allele loss at the BRCA1 locus. Mutations were detected in 3 of 32 breast and 1 of 12 ovarian carcinomas; all four mutations were germline alterations and occurred in early-onset cancers. These results suggest that mutation of BRCA1 may not be critical in the development of the majority of breast and ovarian cancers that arise in the absence of a mutant germline allele.
引用
收藏
页码:120 / 122
页数:3
相关论文
共 50 条
  • [21] Secondary BRCA1/2 mutations are associated with platinum resistance in a large series of BRCA1/2-mutated ovarian carcinomas
    Norquist, B.
    Sakai, W.
    Wurz, K.
    Karlan, B.
    Taniguchi, T.
    Swisher, E.
    GYNECOLOGIC ONCOLOGY, 2010, 116 (03) : S4 - S4
  • [22] BRCA1 and BRCA2 Mutations in Ovarian Cancer
    Buerkle, Bernd
    Tempfer, Clemens
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2012, 307 (04): : 359 - 359
  • [23] Prevalence of BRCA1 and BRCA2 mutations in Pakistani breast and ovarian cancer patients
    Rashid, Muhammad U.
    Zaidi, Anbreen
    Torres, Diana
    Sultan, Faisal
    Benner, Axel
    Naqvi, Bilal
    Shakoori, Abdul R.
    Seidel-Renkert, Antje
    Farooq, Humirah
    Narod, Steven
    Amin, Asim
    Hamann, Ute
    INTERNATIONAL JOURNAL OF CANCER, 2006, 119 (12) : 2832 - 2839
  • [24] Germline mutations of the BRCA1 and BRCA2 genes in a breast and ovarian cancer patient
    Randall, TC
    Bell, KA
    Rebane, BA
    Rubin, SC
    Boyd, J
    GYNECOLOGIC ONCOLOGY, 1998, 70 (03) : 432 - 434
  • [25] A breast/ovarian cancer patient with germline mutations in both BRCA1 and BRCA2
    Ramus, SJ
    Friedman, LS
    Gayther, SA
    Ponder, BAJ
    Bobrow, LG
    vanderLooji, M
    Papp, J
    Olah, E
    NATURE GENETICS, 1997, 15 (01) : 14 - 15
  • [26] Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2
    King, MC
    Marks, JH
    Mandell, JB
    SCIENCE, 2003, 302 (5645) : 643 - 646
  • [27] Cancers Associated With BRCA1 and BRCA2 Mutations Other Than Breast and Ovarian
    Mersch, Jacqueline
    Jackson, Michelle A.
    Park, Minjeong
    Nebgen, Denise
    Peterson, Susan K.
    Singletary, Claire
    Arun, Banu K.
    Litton, Jennifer K.
    CANCER, 2015, 121 (02) : 269 - 275
  • [28] BRCA1 and BRCA2 mutations in Ashkenazi Jewish families with breast and ovarian cancer
    Schubert, EL
    Mefford, HC
    Dann, JL
    Argonza, RH
    Hull, J
    King, MC
    GENETIC TESTING, 1997, 1 (01): : 41 - 46
  • [29] BRCA1 and BRCA2 mutations in Danish families with hereditary breast and/or ovarian cancer
    Thomassen, Mads
    Hansen, Thomas V. O.
    Borg, Ake
    Lianee, Henriette Theilmann
    Wikman, Friedrik
    Pedersen, Inge Sokilde
    Bisgaard, Marie Luise
    Nielsen, Finn C.
    Kruse, Torben A.
    Gerdes, Anne-Marie
    ACTA ONCOLOGICA, 2008, 47 (04) : 772 - 777
  • [30] A breast/ovarian cancer patient with germline mutations in both BRCA1 and BRCA2
    Suman J. Ramus
    Lori S. Friedman
    Simon A. Gayther
    Bruce A.J. Ponder
    Lynda G. Bobrow
    Marco van der Looji
    Janos Papp
    Edith Olah
    Nature Genetics, 1997, 15 : 14 - 15